Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11347292 | 0.89 | PDK2 (0.50) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL23371529 | 0.88 | PDK2 (0.40) | PDK2BACE1CA1CA4CA7 | |
| SCHEMBL23371609 | 0.88 | PDK2 (0.40) | PDK2BACE1CA1CA4CA7 | |
| SCHEMBL29587737 | 0.84 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL204806 | 0.84 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL29403081 | 0.84 | PDK2 (0.44) | PDK2CA1CA2CA4CA7 | |
| SCHEMBL31606157 | 0.83 | SNCA (0.46) | MEN1KMT2ATP53SMN1; SMN2MAPT | |
| SCHEMBL23371443 | 0.82 | MEN1 (0.37) | PDK2BACE1MEN1KMT2ATP53 | |
| SCHEMBL15953222 | 0.82 | PTPN1 (0.42) | PDK2BACE1MEN1KMT2ATP53 | |
| SCHEMBL16465285 | 0.81 | CYP3A4 (0.38) | BACE1CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11563180-B2 | Spirobifluorene compound and perovskite solar cell comprising same | KOREA RESEARCH INSTITUTE OF CHECMICAL TECHNOLOGY (KR) | 2023-01-24 | — | — | US | disclosed |
| US-20190288207-A1 | SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2019-09-19 | — | — | US | disclosed |
| WO-2018088797-A1 | SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME | 한국화학연구원 | 2018-05-17 | — | — | WO | disclosed |
| US-8932735-B2 | Aromatic amine derivative and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| US-20080119499-A1 | Compositions Havinge Improved 2-Photon Absorbance For Nonlinear Applications | MEMPILE INC. (DE) | 2008-05-22 | — | — | US | disclosed |
| US-20080119499-A1 | Compositions Havinge Improved 2-Photon Absorbance For Nonlinear Applications | MEMPILE INC. (DE) | 2008-05-22 | — | — | US | disclosed |
| US-20080119499-A1 | Compositions Havinge Improved 2-Photon Absorbance For Nonlinear Applications | MEMPILE INC. (DE) | 2008-05-22 | — | — | US | disclosed |
| EP-1842097-A1 | COMPOUNDS HAVING IMPROVED 2-PHOTON ABSORBANCE FOR NONLINEAR APPLICATIONS | Mempile Inc. (US) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006075328-A1 | COMPOUNDS HAVING IMPROVED 2-PHOTON ABSORBANCE FOR NONLINEAR APPLICATIONS | MEMPILE INC. (US) | 2006-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | AOC2, AOC3, H1-4 | PDK2 1661/4885BACE1 1656/4885CA1 1830/4885 |
| US-11563180-B2 | Spirobifluorene compound and perovskite solar cell comprising same | SLC9B2, STOM, SLC46A1 | PDK2 332/4885BACE1 3143/4885CA1 3347/4885 |
| US-20190288207-A1 | SPIROBIFLUORENE COMPOUND AND PEROVSKITE SOLAR CELL COMPRISING SAME | SLC9B2, STOM, SLC46A1 | PDK2 332/4885BACE1 3143/4885CA1 3347/4885 |
| US-20080119499-A1 | Compositions Havinge Improved 2-Photon Absorbance For Nonlinear Applications | HTR3D, CRY2, CNDP2 | PDK2 1334/4885BACE1 2185/4885CA1 938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.